Your session is about to expire
← Back to Search
Genetic Testing
Genetic-Guided Pharmacologic Therapy for High Blood Pressure (PGEN for HTN Trial)
Phase 2
Waitlist Available
Led By Pamela Phelps, PharmD
Research Sponsored by Geneticure, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial is looking at whether or not using genetic information to guide blood pressure therapy can help improve treatment and decrease the time to blood pressure control.
Eligible Conditions
- High Blood Pressure
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Blood Pressure
Number of Blood Pressure Medicines
Time to Blood Pressure Control
Secondary study objectives
Pharmaceutical Preparations
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Genetically-Guided Treatment for HTNExperimental Treatment1 Intervention
Using a patient's genetic composition to guide BP prescribing for patients with hypertension, post diagnosis.
Group II: JNC-8-Guided TreatmentActive Control1 Intervention
Using traditional (JNC-8) guidelines for BP prescribing for patients with hypertension, post diagnosis.
Find a Location
Who is running the clinical trial?
Fairview Health ServicesOTHER
6 Previous Clinical Trials
2,128 Total Patients Enrolled
Geneticure, LLCLead Sponsor
3 Previous Clinical Trials
887 Total Patients Enrolled
University of MinnesotaOTHER
1,423 Previous Clinical Trials
1,618,785 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have high blood pressure caused by another medical condition.Your kidney disease has been diagnosed by a blood test that shows high creatinine levels.You are between 30 and 80 years old.Your liver is not working properly, as determined by specific lab test results or diagnosed liver disease.You have been diagnosed with serious heart problems like coronary artery disease, heart failure, or congenital heart disease.You have been diagnosed with significant blood vessel disease in your arms, legs, or lungs.You have a history of hormone-related conditions, except for mild type 2 diabetes and well-managed hypothyroidism.You have recently been diagnosed with high blood pressure or have high blood pressure that is not well controlled with one medication.You have a body mass index (BMI) between 19 and 50.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: JNC-8-Guided Treatment
- Group 2: Genetically-Guided Treatment for HTN
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger